Literature DB >> 9893751

Upregulation of ATM in sclerosing adenosis of the breast.

R A Clarke1, R Kairouz, D Watters, M F Lavin, J H Kearsley, C S Lee.   

Abstract

The gene mutated in ataxia telangiectasia (ATM) has an established tumour suppressor role in breast cancer. ATM appears to be expressed in most normal cells, including breast epithelium, where it has been postulated to have a nuclear role in cell cycle regulation following DNA damage. However, ATM is not upregulated after DNA damage. In this study, we demonstrate an absence of immunohistologically detectable levels of ATM in the normally quiescent myoepithelial cells that line normal breast ducts. This contrasts dramatically with the significant expression of ATM in the proliferative myoepithelium of sclerosing adenosis (n = 7). This upregulation of ATM suggests that ATM expression is coupled to the proliferative status of the myoepithelium. Our results also indicate that there are factors other than ATM gene mutations that can dramatically influence ATM expression in the breast and that these factors should be considered for their possible implications in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893751      PMCID: PMC395642          DOI: 10.1136/mp.51.4.224

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  41 in total

Review 1.  HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology.

Authors:  H Budka; C A Wiley; P Kleihues; J Artigas; A K Asbury; E S Cho; D R Cornblath; M C Dal Canto; U DeGirolami; D Dickson
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

2.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.

Authors:  S R Shi; M E Key; K L Kalra
Journal:  J Histochem Cytochem       Date:  1991-06       Impact factor: 2.479

3.  Faecally derived hydrolytic enzymes from Dermatophagoides pteronyssinus: physicochemical characterisation of potential allergens.

Authors:  G A Stewart; F R Lake; P J Thompson
Journal:  Int Arch Allergy Appl Immunol       Date:  1991

4.  Ultrastructural localization of the allergen Der p I in the gut of the house dust mite Dermatophagoides pteronyssinus.

Authors:  B Thomas; P Heap; F Carswell
Journal:  Int Arch Allergy Appl Immunol       Date:  1991

5.  Conformational stability of B cell epitopes on group I and group II Dermatophagoides spp. allergens. Effect of thermal and chemical denaturation on the binding of murine IgG and human IgE antibodies.

Authors:  M Lombardero; P W Heymann; T A Platts-Mills; J W Fox; M D Chapman
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

6.  Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method.

Authors:  K Kure; W D Lyman; K M Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

7.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

Authors:  R W Shin; T Iwaki; T Kitamoto; J Tateishi
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

8.  HIV-p24-antigen-bearing macrophages are only present in brains of HIV-seropositive patients with AIDS-encephalopathy.

Authors:  J Schindelmeiser; F Gullotta
Journal:  Clin Neuropathol       Date:  1991 May-Jun       Impact factor: 1.368

9.  Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases.

Authors:  F Gray; M C Lescs; C Keohane; F Paraire; B Marc; M Durigon; R Gherardi
Journal:  J Neuropathol Exp Neurol       Date:  1992-03       Impact factor: 3.685

10.  Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy.

Authors:  O Brüstle; H Spiegel; S L Leib; T Finn; H Stein; P Kleihues; O D Wiestler
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more
  7 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  ATM protein synthesis patterns in sporadic breast cancer.

Authors:  R Kairouz; R A Clarke; P J Marr; D Watters; M F Lavin; J H Kearsley; C S Lee
Journal:  Mol Pathol       Date:  1999-10

3.  Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias.

Authors:  Jane Starczynski; William Simmons; Joanne R Flavell; Phillip J Byrd; Grant S Stewart; Harjit S Kullar; Alix Groom; John Crocker; Paul A H Moss; Gary M Reynolds; Meri Glavina-Durdov; A Malcolm R Taylor; Christopher Fegan; Tatjana Stankovic; Paul G Murray
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

4.  The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.

Authors:  Nisreen Al-Moghrabi; Asmaa Nofel; Nujoud Al-Yousef; Safia Madkhali; Suad M Bin Amer; Ayodele Alaiya; Zakia Shinwari; Taher Al-Tweigeri; Bedri Karakas; Asma Tulbah; Abdelilah Aboussekhra
Journal:  BMC Cancer       Date:  2014-11-17       Impact factor: 4.430

5.  Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast.

Authors:  S Angèle; C Jones; J S Reis Filho; L G Fulford; I Treilleux; S R Lakhani; J Hall
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

6.  Variation of ATM Gene Expression in Peripheral Blood Cells of Sporadic Breast Carcinomas in Iranian Patients.

Authors:  Mohsen Foroughizadeh; Hossein Mozdarani; Keyvan Majidzadeh-A; Ahmad Kaviani
Journal:  Avicenna J Med Biotechnol       Date:  2012-04

7.  Translational initiation regulated by ATM in dendritic cells development.

Authors:  E Y So; T Ouchi
Journal:  Cell Death Dis       Date:  2014-09-11       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.